Starling Oncology, Inc. Cash Equivalents, at Carrying Value
Starling Oncology, Inc. (DFPH) had Cash Equivalents, at Carrying Value of $0 as of 2020-12-31, per its 10-K/A filed 2021-12-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2021-12-14
- 2020-12-31: Cash Equivalents, at Carrying Value $0.00.
- 2019-12-31: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2020-12-31 | $0.00 10-K/A · filed 2021-12-14 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-12-14 |